After menopause, cardiovascular health scores predict mortality - and body fat helps explain why

Published March 18, 2026 in Menopause, the journal of The Menopause Society.

Can a single score predict how long you live after menopause?

The American Heart Association maintains two composite health scores designed to summarize cardiovascular well-being in a single number. Life's Essential 8 (LE8) captures eight factors - diet, physical activity, nicotine exposure, sleep, body mass index, blood lipids, blood glucose, and blood pressure. Life's Crucial 9 (LC9) adds a ninth component. Both condense complex biology into a score from 0 to 100.

The appeal of such scores is obvious: a quick, standardized way to assess cardiovascular risk. But how well do they actually predict hard outcomes - death, specifically - in postmenopausal women? And if they do predict mortality, what biological mechanisms drive that link? A new study published in Menopause, the journal of The Menopause Society, offers answers to both questions.

Tracking 7,800 women through follow-up

The researchers examined more than 7,800 postmenopausal women, of whom 1,313 died during the follow-up period. The analysis measured each participant's LE8 and LC9 scores and then tracked all-cause and cardiovascular mortality. The relationship was clear and consistent: higher scores on both metrics correlated with lower risk of death from any cause and lower risk of death from cardiovascular disease specifically.

That much was expected. Higher cardiovascular health scores have been associated with better outcomes in multiple populations. What this study added was the next logical question: why? What biological pathways connect a composite health score to actual survival?

Fat redistribution and chronic inflammation as mediators

The researchers performed mediation analyses - statistical techniques designed to identify whether a third variable explains part of the relationship between an exposure and an outcome. They tested two candidate mediators: adiposity-related indicators (measures of body fat and its distribution) and inflammation-related indicators (markers of systemic inflammatory activity).

Both partially mediated the association between cardiovascular health scores and mortality. In plain terms: women with lower LE8 and LC9 scores tended to carry more body fat, particularly around the midsection, and exhibited higher levels of inflammatory markers. These factors, in turn, were associated with higher mortality risk. Remove their statistical contribution, and the association between health scores and death weakened - though it did not disappear entirely, suggesting other mechanisms also play a role.

This matters because menopause triggers specific physiological changes that amplify both pathways. Declining estrogen levels promote redistribution of body fat from subcutaneous stores to visceral deposits around the abdomen. Visceral fat is metabolically active tissue that secretes inflammatory cytokines, creating a feedback loop: more visceral fat drives more inflammation, which accelerates cardiovascular damage.

What the scores actually measure in this population

The practical implication is that LE8 and LC9 scores are not abstract numbers for postmenopausal women - they reflect real physiological processes with measurable consequences. A woman whose score drops after menopause is likely experiencing the fat redistribution and inflammatory escalation that this study links to mortality.

Dr. Stephanie Faubion, medical director for The Menopause Society, emphasized the actionable nature of the findings. The lifestyle factors captured by these scores - diet, exercise, sleep, smoking status - are modifiable. Women who maintain favorable profiles across these dimensions appear to partially counteract the metabolic shifts that menopause initiates.

The word "partially" deserves emphasis. The mediation was not complete. Adiposity and inflammation explained a meaningful fraction of the mortality association but not all of it. Other pathways - vascular stiffening, autonomic nervous system changes, shifts in coagulation factors - likely contribute as well but were not measured in this study.

Observational data and its inherent limits

This is an observational study, which means it identifies associations rather than proving causation. Women with higher cardiovascular health scores differ from those with lower scores in many ways, not all of which can be statistically controlled. Socioeconomic status, access to healthcare, genetic predisposition, and psychological factors all influence both health behaviors and mortality risk.

The mediation analysis, while statistically rigorous, relies on assumptions about causal ordering that observational data cannot fully validate. The researchers assume that health scores influence adiposity and inflammation, which then influence mortality. But the relationships could run in different directions: chronic illness, for instance, might simultaneously lower health scores, alter body composition, and increase mortality risk without adiposity being a true mediating mechanism.

The study population consisted entirely of postmenopausal women, which limits generalizability to premenopausal women or men. The specific inflammatory and adiposity markers used may not capture the full complexity of these biological processes. And the LC9 score's additional ninth component, while potentially more comprehensive than LE8, has less validation in the literature.

The follow-up period and cause-of-death ascertainment methods were not detailed in the press release, so it is difficult to assess whether the mortality data captured cardiovascular deaths accurately or whether misclassification might have influenced the results.

Modifiable factors in an unmodifiable transition

Menopause is not a disease, and it is not preventable. But the metabolic cascade it triggers - visceral fat accumulation, rising inflammation, deteriorating lipid profiles, increasing insulin resistance - is at least partially modifiable through the same behavioral factors that LE8 and LC9 measure. The value of this study lies not in discovering that healthy behaviors are beneficial, which is hardly news, but in quantifying the specific biological pathways through which those behaviors may protect postmenopausal women from premature death.

For clinicians, the message is that cardiovascular risk assessment after menopause should look beyond traditional risk factors and consider the interplay between adiposity, inflammation, and overall health behaviors. For women navigating this transition, the data supports what the best clinical advice has long recommended: that sustained attention to diet, movement, sleep, and body composition pays dividends that compound over decades.